Compare studies and check their requirements with the research team.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about ADHD.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about ADHD.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about ADHD.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In GermanyThis study is directly about ADHD.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In NetherlandsThis study is directly about ADHD.
This study is looking at whether Children will be randomized in equal numbers to NFPP and the control condition can help people with Attention Deficit Hyperactivity Disorder or Mental and Behavioural Disorders. Participants take part in Children will be randomized in equal numbers to NFPP and the control condition and complete follow-up assessments.
In United KingdomThis study is directly about ADHD.
This summary needs review. Please check the official study record and contact the research team for details.
In BostonThis study is directly about ADHD.
This study was terminated in Australia. It focuses on ADHD.
In MelbourneThis study is directly about ADHD.
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis study is directly about ADHD.
This summary needs review. Please check the official study record and contact the research team for details.
In NijmegenThis study is directly about ADHD.
This study is completed. It is testing Safety and Dopamine Transporter Binding Properties of C-11 Altropane for ADHD.
Location not clearly listedThis study is directly about ADHD.
This summary needs review. Please check the official study record and contact the research team for details.
In TucsonThis study is directly about ADHD.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.